Partners Carlos Sanz and Rupprecht Pranckh discuss how the London-headquartered firm has built up its specialization in biological inputs and farmer productivity since 2017.
Bridgepoint continues build-out of ag biologicals portfolio; Stafford Capital Partners closes SIT X on $1.04 billion; Rohatyn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback